Advertisement

Topics

MiMedx to divest Stability Biologics business to focus on biopharma

19:00 EDT 21 Aug 2017 | Pharmaceutical Technology

MiMedx Group has signed a new definitive agreement with former stockholders of Stability to sell its subsidiary, Stability Biologics, back to the stockholders to focus on biopharma.

Original Article: MiMedx to divest Stability Biologics business to focus on biopharma

NEXT ARTICLE

More From BioPortfolio on "MiMedx to divest Stability Biologics business to focus on biopharma"

Advertisement
Quick Search
Advertisement
Advertisement

 

Relevant Topics

Collaborations in biotechnology
Commercial and academic collaborations are used throughout the biotechnology and pharmaceutical sector to enhance research and product development. Collaborations can take the form of research and evaluation agreements, licensing, partnerships etc. ...

Biotherapeutics
The field encompassing therapeutic materials produced using biological means, including recombinant DNA technology. Biotherapeutics, also known as biotech drugs or biologics, are therapies derived from living organisms. By harnessing these living cells...